Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP2 | O95551 | 2/20 | 0.56 |
| ▸ | NSD2 | O96028 | 2/20 | 0.56 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.56 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.56 |
| ▸ | CES1 | P23141 | 1/20 | 0.56 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | GSK3B | P49841 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CDC25B | P30305 | 3/20 | 0.50 |
| ▸ | S100A4 | P26447 | 3/20 | 0.50 |
| ▸ | PTPRC | P08575 | 2/20 | 0.50 |
| ▸ | CTSL | P07711 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30534404 | 1.00 | TDP2 (0.56) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL13442892 | 0.88 | TDP2 (0.63) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL2800822 | 0.82 | TDP2 (0.50) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL12538393 | 0.78 | TDP2 (0.50) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL3500581 | 0.73 | ALDH1A1 (0.37) | TDP2NSD2PAX8ABL1PLCG1 | |
| Phanquone SCHEMBL462025 | 0.72 | MEN1 (1.00) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL5915065 | 0.72 | TDP2 (0.81) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL460433 | 0.72 | TDP2 (1.00) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL29551149 | 0.72 | GAA (1.00) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL29419580 | 0.72 | TDP2 (1.00) | TDP2NSD2PAX8ABL1PLCG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094660-A | Composition in the form of an oil-in-water emulsion | — | 2026-05-26 | — | — | CN | claimed |
| EP-4687829-A1 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2026-02-11 | — | — | EP | claimed |
| US-20250381116-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | OREAL (FR) | 2025-12-18 | — | — | US | claimed |
| US-20250161201-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | claimed |
| WO-2025091220-A2 | COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| WO-2025091239-A1 | COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| EP-4543408-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | L'OREAL (FR) | 2025-04-30 | — | — | EP | claimed |
| CN-119654151-A | Composition for caring skin | 莱雅公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119630382-A | Solubilization of thiopyridone compounds and compositions containing same | 莱雅公司 | 2025-03-14 | — | — | CN | claimed |
| EP-4479146-A1 | COSMETIC COMPOSITION | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| EP-1042315-A1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | Klinge Pharma GmbH (DE) | 2000-10-11 | — | — | EP | claimed |
| WO-1999031087-A1 | CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | claimed |
| US-5849916-A | Process for the preparation of 2,3-pyridinedicarboximides | AMERICAN CYANAMID COMPANY (US) | 1998-12-15 | — | — | US | claimed |
| EP-0663399-B1 | Pyridine-2,3-dicarboxylic imides, process for their preparation and their use to control the growth of unwanted plants | BASF AG (DE) | 1998-06-10 | — | — | EP | claimed |
| EP-0661282-B1 | Pyridine-2,3-dicarboxylic imides, process for their preparation and their use to control the growth of unwanted plants | BASF AG (DE) | 1998-04-22 | — | — | EP | claimed |
| EP-0812843-A2 | Process for the preparation of 2,3-pyridinedicarboximides | American Cyanamid Company (US) | 1997-12-17 | — | — | EP | claimed |
| US-5679622-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-21 | — | — | US | claimed |
| US-5571774-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-11-05 | — | — | US | claimed |
| EP-0343108-B1 | Resin compositions | CIBA GEIGY AG (CH) | 1994-08-31 | — | — | EP | claimed |
| US-4981888-A | Resin compositions | CIBA-GEIGY CORPORATION (US) | 1991-01-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161201-A1 | COSMETIC COMPOSITION | CYP19A1, SHBG, HSD17B11 | TDP2 3897/4885NSD2 2140/4885PAX8 2697/4885 |
| US-20250381116-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | TBCB, CCNB3, CYP24A1 | TDP2 1001/4885NSD2 2271/4885PAX8 1791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.